1/36
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai |
|---|
No analytics yet
Send a link to your students to track their progress
What are the biological effects of ionising radiation on cells?
DNA strand breaks
H2O conversion into H2O+ and e-
H2O+ is a ROS which can dissociate to produce OH- OR react with water to produce H3O+ and OH-
What are alkylating agents?
Reactive compounds which can donate an alkyl group to other molecules
Methylation of nucleotides is the primary mechanism of toxicity
What is a methylating agent?
Reactive compound which donates CH3 to other molecules.
What is an ethylating agent?
Reactive compound which donates CH2H5 to other molecules.
What is a chloromethylating agent?
Reactive compound which donates CH2Cl to other molecules.
Alkylating agents can broadly be grouped based on the number of reactive groups. These two groups are:
Monofunctional
Only reacts with one strand of DNA
Bifunctional
Can react with two strands of DNA
This allows formation of cross-links between two strands of DNA
Why does methylation of nucleotides result in cell toxicity?
The methylated nucleotides behave very differently
O6-methylguanine has very different biological effects to guanine
What are Topoisomerase inhibitors?
Topoisomerases are important enzymes responsible for cleaving the DNA
Inhibitors interfere with the enzymes and result in the formation of protein-capped DNA double strand breaks
What is type 1 topoisomerase enzyme?
Type I – Cleave single DNA strand
Allows for strand unwinding and torsion release
What is type 2 topoisomerase enzyme?
Type II – Cleave double DNA strand
Allows for untangling of DNA strands
How do topoisomerase inhibitors result in cell toxicity?
Inhibitors can result in formation of a protein-capped DNA double strand break
Traps the enzyme on the DNA causing breaks
This is recognised by the cell, and this either results in cell death or a mutation if the cell tries to repair it
Why are anti-cancer agents toxic and mutagenic to healthy cells?
Majority of chemotherapy disrupt DNA replication/cell division
These target cells with high rate of proliferation such as cancer but also healthy fast growing cells
Causes loss of hair follicles, GI mucosa and B/T lymphocytes
Immediate effects as a result of acute toxicity
What are the long term effects of Cisplatin, Bleomycin and Radiation?
Infertility
Cognitive impairment
Hypogonadism (Impaired function of gonads – low testosterone)
Premature ageing
Type II diabetes
Cardiovascular disease
Pulmonary toxicity
Nephrotoxicity
Kidneys
Ototoxicity
Ears
What socioeconomic effects does cytotoxic cancer therapy have?
Low social engagement
High unemployment
Sedentary lifestyle
Depression and Anxiety
What is an example of a life threatening late effect of cancer therapy?
Myocytic vacuoles
Clear areas which are void of cardiac myocyte fibres
Ultimately causes an increased risk of heart failure
What cancer therapy can cause myocytic vacuoles?
Anthracyclines (Doxorubicin and Daunorubicin)
Targets cardiac myocytes
Reaction with iron causes production of ROS
Apoptosis
Cardiac fibrosis
How do Anthracyclines work?
Topoisomerase II inhibitors
Causes lethal double-strand DNA breaks
Can also intercalate into DNA and generate ROS leading to apoptosis
Recent studies also suggest they can cause the loss of histones resulting in DNA damage
What is treatment related cancer?
Cancer which develops because of therapy for a primary cancer
The biggest single cause of death in long-term Hodgkin Lymphoma survivors is…
Second cancer is the biggest single cause of death in long-term Hodgkin Lymphoma survivors
Most known chemotherapy regiments and radiotherapy are known or suspected human carcinogens
E.g. MOPP and ABVD
Secondary cancer development due to treatment is equally likely to cause cancer in any tissue in the body.
True or False?
False.
Tissues can differ in their relative sensitivity to the carcinogenic effects of treatment
E.g. Colon and breast cancer are relatively less common compared to acute myeloid leukaemia (AML)
How can topoisomerase inhibitors result in cancer development?
Hint: Secondary leukaemia
Can target the mixed lineage leukaemia (MLL) gene which is associated with secondary leukaemia
Can cause cleavage near the gene resulting in MLL translocation onto other chromosomes
MLL gene encodes a large protein which functions as a histone methyltransferase
Allows it to regulate transcription
Translocation can result in fusion gene production which can produce oncofusion proteins which aberrantly upregulate transcription of genes involved in cell proliferation
How can alkylating agents induce leukaemia?
Addition of methyl group to O6 of guanine can produce O6-methylguanine
This molecule is highly mutagenic
Can align with T rather than C due to its O6 oxygen no longer being able to produce hydrogen bonds
This can introduce a point mutation
Why is bone marrow more susceptible to transformation by alkylating agents?
Relatively little Methylguanine Methyltransferase (MGMT) compared to DNA within myeloid precursors
MGMT is involved in repair of O6-methylguanine back into guanine
Suggests bone marrow is more susceptible to alkylating agents due to low levels of DNA repair proteins like MGMT
How is radiotherapy able to induce cancer development?
Radiotherapy cause DNA damage in some cells
An initial failure to repair the damage or apoptose the cell results in the DNA damage being fixed as a mutation in rapidly dividing cells
These rapidly dividing cells could then transform
This then leads to rapid clonal expansion which leads to cancer development
In the case of breast cancer, what has been shown to be protective against radiogenic cancer?
Evidence suggests that chemotherapy can protect against radiogenic breast cancer
Radiotherapy alone conferred a greater risk of breast cancer than radiotherapy and chemotherapy combined
Why is it thought that chemotherapy can protect against radiogenic breast cancer?
Thought that the chemotherapy is impacting oestrogen function in the ovaries which reduces proliferation of developing breast cancer
This helps protect against radiogenic breast cancer development
In the case of breast cancer, what has been shown to increase the risk of radiogenic cancer?
Oestrogen has been shown to increase the risk of radiogenic breast cancer.
How does age at exposure to cancer treatment impact on acute myeloid leukaemia development?
For acute myeloid leukaemia, age has a limited impact on relative risk
Risk drops with increasing age, but risk remains high throughout life
How does age at exposure to cancer treatment impact on breast/thyroid cancer development?
For breast/thyroid cancer, the risk is very high early on in life (<21)
Why is it thought that younger women are more at risk of secondary breast cancer development due to cancer therapy?
When young women’s breast tissue is developing, cell division rate is very high
Exposing these cells to cancer treatment increases the risk of transforming the tissue
Generates DNA damage
Once the breasts stop developing, the cells have more time to repair damage and can better avoid transforming
When treating Hodgkin’s Lymphoma, what treatment related effect can occur in males?
Males
Susceptible to gonadal toxicity from alkylating agent chemotherapy
When treating Hodgkin’s Lymphoma, what treatment related effect can occur in females?
Females
Substantial risk of breast cancer after chest radiation
What are examples of cancers which Imatinib is used to treat?
Chronic myeloid leukaemia (CML) and Acute Lymphoblastic Leukaemia (ALL)
Which are Ph chromosome positive
What is Rituximab used to treat?
B-cell Lymphomas
Targets CD20 and causes ADCC, CDC and apoptosis
What is Iplimumab used to treat?
Lymphomas
Anti-CTLA-4 antibody which prevents T-cell inhibition
What is Rucaparib used to treat?
Breast, ovarian and prostate cancer
Inhibitor of PARP enzymes, blocking single-strand DNA break repair
Effective in BRCA-deficient cancer
Current data about newer targeted therapies seems to suggest they are just as likely to transform healthy tissue and cause secondary cancers.
True or False?
False.
Current data seems to suggest that these therapies are much less likely to transform healthy tissue